Cost & Insurance
What to Ask Your Insurance About Weight Loss Medication
A checklist of questions to ask your health plan about weight loss medication coverage, prior authorization, copays and appeals before you start treatment.
Self-Pay Weight Loss Medication and Compounded Drugs
How self-pay works for weight loss medication in Illinois, manufacturer cash programs, and why FDA-approved medication differs from compounded copies.
Prior Authorization and Appeals for Weight Loss Medication
How prior authorization works for weight loss medication, how to appeal a denial, and how Illinois external review works.
When Your Employer Plan Excludes Weight Loss Drugs
What to do in Illinois if your employer health plan excludes weight loss medication: check the exclusion, ask HR, compare self-pay and HSA or FSA options.
Illinois State Employee Plan and Weight Loss Medication
What the State Employees Group Insurance Program requires for injectable weight loss and blood sugar medications, who qualifies, and the lifestyle program condition.
Blue Cross Blue Shield of Illinois and Weight Loss Medication
How to find out whether your Blue Cross and Blue Shield of Illinois plan covers prescription weight loss medication, what prior authorization involves, and what to do if it does not.
Cash-Pay vs. Insurance for Weight Loss Treatment in Illinois
Cash-pay or insurance for weight loss medication in Illinois? An honest comparison of cost, speed, choice and paperwork.
Can I Use an HSA or FSA for Weight Loss Treatment?
Can you pay for physician-prescribed weight loss treatment with an HSA or FSA? What to ask your plan administrator. General information, not tax advice.
TeleSlim Clinic Pricing and Plans in Illinois
TeleSlim Clinic Illinois plans: $99 initial visit, $99 monthly, $269 for 3 months, $499 for 6 months, $899 annual. What each includes.
Does Illinois Medicaid Cover Wegovy or Zepbound?
Does Illinois Medicaid cover weight loss drugs like Wegovy and Zepbound? What is generally covered, what is not, and how to confirm for your plan.

